Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting.
Journal Information
Full Title: Antiviral Res
Abbreviation: Antiviral Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"appendix a supplementary data the following is the supplementary data to this article: multimedia component 1 multimedia component 1 data availability raw data are available at 10 6084/m9 figshare 20338695 . data availability raw data are available at 10 6084/m9 figshare"
"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
"Funding This work was supported by the Swiss National Science Foundation [PZ00P3_193,289 to V.C.] and the University Hospital of Geneva PRD financing to V.C and L.K., and by the 10.13039/100015846Welsh Government Office for Science Sêr Cymru Tackling COVID-19 grant to C.V.. Funding for open access charge: Swiss National Science Foundation."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025